Abstract
In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these aims are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control in phenylketonuria, especially in older rather than younger children.
Original language | English |
---|---|
Pages (from-to) | 55-57 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 360 |
Issue number | 9326 |
DOIs | |
Publication status | Published - 6 Jul 2002 |
Keywords
- Adolescent
- Adult
- Child
- Child, Preschool
- Humans
- Infant
- Multicenter Studies as Topic
- Patient Compliance
- blood: Phenylalanine
- diet therapy: Phenylketonurias
- Treatment Outcome